Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 26 February 2017
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 26 February 2017. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): will be drawn down in 2 tranches against pro rata deliveries made/services rendered in accordance with the relevant provisions under the export contract by M/s Ferrostaal Equipment Solutions, GmbH, Germany and HERMES for ECA premium. The loan will attract interest at the rate of 2.15% per annum above LIBOR in addition. The lender will receive management fees and commitment fees. Repayment will be made over 5 years excluding delivery and commissioning period in (cont. 2)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005ff43
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.